Benzotriazole

Benzotriazole

SCHEMBL14975745

Cc1ccc(N)cc1.c1ccc2[nH]nnc2c1

nearest known ligand 0.45

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ACHE P22303 1/20 0.45
RAB9A P51151 7/20 0.40
NPC1 O15118 6/20 0.40
ALDH1A1 P00352 5/20 0.40
MAPT P10636 3/20 0.40
KDM4E B2RXH2 3/20 0.40
TP53 P04637 3/20 0.40
POLB P06746 3/20 0.40
SMN1; SMN2 Q16637 3/20 0.40
GFER P55789 2/20 0.40
HSD17B10 Q99714 2/20 0.40
HPGD P15428 2/20 0.40
MEN1 O00255 3/20 0.37
KMT2A Q03164 3/20 0.37
CYP1A2 P05177 2/20 0.37
CYP1A1 P04798 1/20 0.37
CYP1B1 Q16678 1/20 0.37
TEAD4 Q15561 1/20 0.37
TDP1 Q9NUW8 1/20 0.36
MLKL Q8NB16 2/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Benzotriazole SCHEMBL18631915 0.85 LMNA (0.44) ACHERAB9ANPC1ALDH1A1MAPT
Benzotriazole SCHEMBL27770572 0.85 TSHR (0.44) ACHERAB9ANPC1ALDH1A1MAPT
Benzotriazole SCHEMBL8621732 0.83 ALDH1A1 (0.45) RAB9ANPC1ALDH1A1MAPTKDM4E
Benzotriazole SCHEMBL22165676 0.81 ALDH1A1 (0.38) RAB9ANPC1ALDH1A1MAPTKDM4E
Benzotriazole SCHEMBL6088869 0.81 ALDH1A1 (0.41) RAB9ANPC1ALDH1A1MAPTKDM4E
Benzotriazole SCHEMBL8956 0.81
Benzotriazole SCHEMBL29381270 0.81
Benzotriazole SCHEMBL1322264 0.81 NQO2 (0.46) RAB9ANPC1ALDH1A1MAPTKDM4E
Benzotriazole SCHEMBL8477124 0.79 L3MBTL1 (0.37) RAB9ANPC1ALDH1A1KDM4ETP53
Benzotriazole SCHEMBL10790175 0.79 ALDH1A1 (0.37) RAB9ANPC1ALDH1A1MAPTKDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20140323418-A1 SELECTIVE KINASE INHIBITORS PORTOLA PHARMACEUTICALS, INC. (US) 2014-10-30 US disclosed
EP-2782580-A1 SELECTIVE KINASE INHIBITORS Portola Pharmaceuticals, Inc. (US) 2014-10-01 EP disclosed
WO-2013078468-A1 SELECTIVE KINASE INHIBITORS PORTOLA PHARMACEUTICALS, INC. (US) 2013-05-30 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20140323418-A1 SELECTIVE KINASE INHIBITORS SYK, BTK, LCK ACHE 4219/4885RAB9A 3210/4885NPC1 4247/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.